Full List Of Stories
26 Jun
Roche meets one primary endpoint in 'ipatasertib' prostate cancer study
Roche said a phase three study of its ipatasertib prostate cancer treatment had met a co-primary endpoint but failed to meet a second co-endpoint.
11 Jun
Morgan Advanced Materials to cut costs after slide in sales
Morgan Advanced Materials said sales for the 21 weeks from 1 January to 24 May were 8. 8% lower on an organic constant-currency basis, compared to the same period last year due to the Covid-19 pandemic.